Covered recipient · General Payments record
JOANNA NIGRELLI
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,236.37
- Reported across 62 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $416.33 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $149.26 | 3 |
| ABBVIE INC. | $72.67 | 4 |
| Novo Nordisk AS | $47.74 | 3 |
| Axsome Therapeutics, Inc. | $38.29 | 2 |
| Acerta Pharma LLC | $32.56 | 2 |
| Alkermes, Inc. | $26.78 | 1 |
| Organon LLC | $20.28 | 1 |
| Astellas Pharma US Inc | $18.19 | 1 |
| Corium, Inc. | $10.56 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.24 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105127289 | CMS |
| ABBVIE INC. | $19.55 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105127291 | CMS |
| ABBVIE INC. | $14.81 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105127293 | CMS |
| ABBVIE INC. | $20.07 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105127295 | CMS |
| Alkermes, Inc. | $26.78 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120563306 | CMS |
| Astellas Pharma US Inc | $18.19 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139375500 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.93 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105813425 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.63 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104297538 | CMS |
| Axsome Therapeutics, Inc. | $17.67 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148290751 | CMS |
| Axsome Therapeutics, Inc. | $20.62 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148290753 | CMS |
| Corium, LLC | $10.56 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100121824 | CMS |
| Lilly USA, LLC | $12.67 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135065199 | CMS |
| Lilly USA, LLC | $12.67 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135067165 | CMS |
| Lilly USA, LLC | $123.92 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135025530 | CMS |
| Novo Nordisk Inc | $14.23 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096993150 | CMS |
| Novo Nordisk Inc | $19.43 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097534937 | CMS |
| Novo Nordisk Inc | $14.08 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096894781 | CMS |
| Organon Llc | $20.28 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136262488 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.